The first national audit of advanced heart failure referrals reveals significant gaps in access to life-prolonging therapies, particularly for women. Women represent just 1 in 3 referrals, despite comparable disease burden.
New York Valves 2026 will unveil groundbreaking clinical science and innovation in transcatheter aortic valve replacement and mitral/tricuspid valve therapies. The conference features 22 late-breaking clinical science presentations that aim to transform the treatment of structural heart disease.
Researchers from The University of Osaka found that treatment with five mRNAs effectively promoted cardiac repair and extended survival in mice with heart failure. The study showed that simultaneous administration of five therapeutic mRNAs reduced heart tissue damage and improved heart function.
A new study by the University of Ottawa suggests that a tiny molecule, methylglyoxal, plays a major role in triggering neurological disorders after a heart attack. The molecule accumulates in the brain following a heart attack and is linked to depression, anxiety, and cognitive decline.
Researchers identified a key protein called PERM1 that is restored in patients whose hearts recover after left ventricular assist device (LVAD) support. PERM1 regulates energy production and contractile function in heart cells, and its normalization is associated with improved cardiac function.
A cohort study found two-thirds of newly diagnosed heart failure patients with reduced ejection fraction didn't undergo left ventricular ejection fraction reassessment, limiting treatment opportunities. Guideline-directed medical therapy was also underutilized among persistent heart failure patients who benefit most from it.
Patients with congenital heart defects are more likely to experience a first acute heart attack at an earlier age, averaging 58 years old. Despite this, there is no difference in mortality rates or risk of further heart attacks between the group with congenital heart defects and those without.
A major international study has identified ways to detect patients with hypertrophic cardiomyopathy at serious risk of sudden death, heart failure or other dangerous outcomes. The findings will help save lives by improving the ability to determine who is at greatest risk and spare low-risk patients from unneeded heart implants.
Researchers found a high-risk subgroup of patients with the 'lemon-on-sticks' phenotype, characterized by low BMI and high WHR, who had poor outcomes and higher all-cause mortality rates compared to other phenotypes. This study highlights the need for personalized therapy in heart failure.
In patients with symptomatic rheumatic heart disease, digoxin significantly reduced the risk of a composite of all-cause death or new-onset or worsening heart failure. The treatment had little risk of toxicity, making it a promising therapeutic option for these patients.
The HF-REVERT trial found that CDR132L improved secondary endpoints, including LVEF and NT-proBNP, but not the primary endpoint of LVESVI. Target engagement was confirmed by decreased plasma levels of microRNA-132. The therapy was well-tolerated with no significant safety concerns.
Treatment with digitalis glycosides reduces worsening heart failure events in HFmrEF and HFrEF patients, suggesting its use as additional therapy to reduce worsening heart failure events. The study found no significant interaction with other important study characteristics.
Researchers found that low-dose digoxin and digitoxin reduced worsening heart failure events in patients with mild-to-moderate heart failure and reduced ejection fraction. The treatment was generally well-tolerated and safe, offering a cheap and effective option for managing the condition.
Dr. Rebecca T. Hahn, MD, is the first imager to receive the TCT Geoffrey O. Hartzler Master Operator Award for her groundbreaking work in imaging structural heart procedures. Her unparalleled expertise has redefined the role of imaging in cardiovascular care.
A global validation study led by NYU Langone Health confirms the accuracy of the American Heart Association's PREVENT tool in predicting cardiovascular disease (CVD) risk for diverse populations. The tool, which considers kidney health and albuminuria levels, was found to be highly effective in identifying patients at high CVD risk.
Patrick T. O'Gara, a master clinician and educator, will receive the TCT 2026 Career Achievement Award for his groundbreaking work in interventional cardiology. The award recognizes his clinical excellence, pioneering research, and mentorship of the next generation of physicians.
High-intensity interval training shows strongest vascular benefits in cardiovascular patients. HIIE consistently improves flow-mediated dilation and vasodilation, with combined high-intensity programs showing the largest estimated effects on endothelial function.
Advances in pediatric heart care have increased survival rates, but a shortage of donor hearts means many children still die waiting. Experts urge a shift from 'perfect' donor hearts to carefully selected organs and technological innovations to expand the donor pool.
Researchers are using space-based experiments to develop new methods for protecting and repairing heart tissue, with the goal of creating more robust tissue engineering techniques. By studying the effects of microgravity on heart tissue, scientists hope to identify new targets for therapy and improve patient outcomes.
Experts at ISHLT's annual meeting explored how countries allocate heart transplants, with a focus on balancing competing priorities like saving the sickest patients and ensuring fairness. The discussion highlighted key differences in global allocation schemes, including France's data-driven model, which aims to prioritize patients base...
Partial heart transplantation replaces only defective valves and related structures, eliminating need for repeat replacements. This procedure can provide thousands of additional valve transplants annually, benefiting young patients worldwide.
Researchers found that people with severe obesity and heart failure have weakened heart muscles, which can be reversed through weight loss. The study identified a chemical change in a protein called troponin I as the underlying cause of this condition.
A new global allocation system is being proposed to address inequities in organ allocation for heart transplants. The proposal aims to reduce disparities and ensure no viable donor heart goes unused globally.
A new multicenter study finds that reoperative surgical mitral valve replacement demonstrates significant long-term survival benefits over transcatheter mitral valve-in-valve procedures in patients with failing bioprosthetic valves. At five years, rSMVR patients had lower mortality and more favorable valve performance.
A recent review highlights how AI enables precision treatment, continuous monitoring and individualized prognostic modeling for heart failure patients. AI integrates large-scale structured electronic health records and multimodal imaging to characterize cardiac structure and function, enhancing diagnostic accuracy.
A randomized trial demonstrated that Left Bundle Branch Area Pacing (LBBAP) is an effective strategy for cardiac resynchronisation in patients with heart failure. LBBAP was found to reduce device-related complications and procedure times compared to biventricular pacing.
Individuals with screening-detected atrial fibrillation have a threefold increased risk of developing heart failure compared to those without AF. The incidence of HF was diagnosed early after AF detection, emphasizing the importance of identifying and treating HF in patients with AF.
Combining resistance training and aerobic exercises significantly enhances aerobic fitness, muscle strength, and walking distance in heart failure patients. Adding resistance training to aerobic workouts increases muscle strength more than exercising aerobically alone.
A new study found that older people who forego necessary dental procedures due to financial barriers may experience heart failure, a heart attack, a stroke, or dementia. The researchers suggest that alleviating upstream factors such as financial constraints could prevent chronic disease.
A post hoc analysis of the Finerenone Trial reveals that sudden death in heart failure was often preceded by modest worsening of symptoms and declining quality of life. The study suggests limited specificity for sudden death among other modes of death, implying a complex trajectory before modes of death.
The EMPEROR-Preserved risk model demonstrated good performance in the FINEARTS-HF trial, showing that baseline risk does not modify the relative treatment effect of finerenone. Finerenone has been shown to have a significant benefit for heart failure patients.
A new study finds that heart failure and atrial fibrillation share similar genetic and molecular mechanisms, suggesting a more nuanced understanding of these two conditions. The research reveals that the pathological response involves multiple cell types communicating with each other, leading to a fundamental shift in how atrial fibril...
A study of over 25,300 participants found that consuming a high amount of dietary salt (4,200mg/day) increases the risk of new-onset heart failure by 15%. Reducing sodium intake could lead to a significant reduction in heart failure cases and deaths.
Registration is now open for TCT 2026, the annual scientific symposium of CRF, taking place October 31 - November 3 in San Diego. The event will feature a dynamic program with groundbreaking research and expert-led tutorials.
A new 4D digital heart model has been shown to improve patient outcomes in cardiac resynchronization therapy (CRT) for heart failure. The model, developed at the University of Calgary, enables personalized pacemaker placement, leading to a 10.8% increase in heart function compared to standard care.
A new AI-powered method predicts peak oxygen consumption with high accuracy, identifying high-risk patients with advanced heart failure. The study's multi-modal model uses cardiac ultrasound images and electronic health records to detect this critical measure.
A new study reveals that prior authorization requirements for heart failure medications can significantly delay pharmacy fills, particularly for those with lower socioeconomic status or Medicaid insurance. The study found that patients with prior authorization prescriptions took three times as long to fill their ARNI prescriptions and ...
Researchers at Rice University developed a CRISPR-based technique that increases mitochondrial production in heart cells, improving energy levels and pumping contractions. The system successfully boosted mitochondrial function in human cell types, animal models, and adult human heart donor tissue.
A new study by Cleveland Clinic and Dyania Health demonstrates the potential of large language models in accurately identifying patients who could benefit from clinical research. The AI system reviewed 1,476 patients and identified 46 as potential matches, resulting in a more diverse patient population.
A study published in European Heart Journal found that nearly half of hospitalised heart failure patients are readmitted within a year, with the risk of death also remaining high. Patients with severely reduced heart function face the highest risk, highlighting the need for careful follow-up and tailored care.
Researchers found that a bacterial metabolite regulates heart function through specific brain cells, revealing a new gut-brain-heart axis. This discovery points to potential therapies for hypertension and heart failure, and may serve as a biomarker for identifying patients at high risk.
A new position statement from CSANZ and ACRA highlights telehealth as a critical tool for increasing access to quality cardiovascular care. The guidance provides best practice guidance for safe use by clinicians while emphasizing patient-centered, culturally inclusive multidisciplinary care.
A recent study published in JAMA Internal Medicine found that oral semaglutide has a potential benefit in reducing heart failure events among people with type 2 diabetes and existing heart failure. The data support the use of oral semaglutide as a treatment option for these patients.
Researchers found that patients seen by cardiologists had lower mortality rates and fewer serious heart problems, including heart attack, sudden failure, or irregular heartbeat. The study suggests close teamwork between surgical and heart teams can improve outcomes after major surgery.
Researchers have developed a non-invasive method to estimate blood oxygen levels in heart failure patients using standard cardiac MRI. This breakthrough could spare thousands from undergoing risky tube procedures, allowing for safer and more frequent monitoring.
A new study from Uppsala University reveals a substantial increase in cardiomyopathy diagnoses in Sweden between 2004 and 2023, associated with high excess mortality rates. The study highlights the need for improved detection and targeted treatments to address this growing public health concern.
A recent study from Penn State College of Medicine researchers found that helper T cells, typically involved in fighting infections, become overly activated in failing human hearts, causing damage. The activation of these T cells highlights the impact of inflammation and immune dysfunction in heart failure.
Researchers at University of California San Diego discover gene therapy restoring connexin-43 improves heart function and extends survival in several forms of arrhythmogenic cardiomyopathy. The approach may have broader therapeutic potential across multiple genetic forms of the disease, addressing a critical unmet need.
Researchers identify circulating extracellular vesicles produced in diseased kidneys as the culprit behind toxicity in the heart. The discovery could lead to the development of a blood test to identify patients at high risk for serious heart problems and novel treatments to prevent and treat heart failure.
Researchers have shown that human hearts can regrow muscle cells after a heart attack, paving the way for new treatments to reverse heart failure. The discovery was made possible by pioneering techniques that use living tissue samples taken from patients during bypass surgery.
A study of 800+ US hospitals and 700,000 patients reveals disparities in care among Asian American subgroups. Filipino and Vietnamese patients are least likely to receive guideline-recommended heart failure care.
Researchers discovered that inhibiting a protein called RBM20 can improve heart filling and flexibility in mice with heart failure. The study also found positive impacts on energy metabolism, mitochondrial function, antioxidant balance, and blood flow.
Adults born with heart defects are at increased risk of cardiac complications as they age. The new guideline provides recommendations for monitoring, counseling, and treating Congenital Heart Disease (CHD), including mental health assessment and physical activity guidance. It also emphasizes the importance of access to ongoing speciali...
A $25M study will enroll 18,000 adults at high risk of heart disease and track their progress using smartphone fitness trackers. The trial aims to prove that increasing physical activity can prevent heart attacks and strokes.
A new study found that calcium accumulation in breast arteries and its progression on mammograms can predict future cardiovascular disease. Women with more severe calcification and those whose calcification worsened over time had a higher risk of heart-related events, such as heart attack, stroke, and death.
Researchers at SwRI and Trinity University are working on a new prodrug to mitigate ischemia/reperfusion injury (IRI), which causes permanent cellular and tissue damage. The team aims to protect against IRI by targeting protein misfolding during cellular stress.
Researchers at Penn State are developing a small, durable ventricular assist device (VAD) specifically designed for young children with heart failure. The PSU Child VAD aims to provide long-term support while waiting for a heart transplant, improving quality of life and outcomes.
Researchers at the University of Maryland School of Medicine have identified a bacterial enzyme called zmpB that can cause fatal heart complications in people infected with pneumonia. The enzyme potentiates the invasion of Streptococcus pneumoniae into the heart, leading to damage and potentially life-threatening outcomes.
A recent study published in the American Journal of Preventive Cardiology found that only 13% of US adults with cardiovascular disease met optimal LDL-C management, highlighting significant gaps between guideline recommendations and clinical care. The study suggests actionable steps to improve adherence, including increased use of non-...
A large study found that people with type 1 and type 2 diabetes have a higher risk of sudden cardiac death, particularly in younger adults. The research also showed that sudden cardiac death contributes to shorter life expectancy for those with diabetes.